The options to minimize the surgical trauma to treat ocular diabetic complications and to improve postoperative recovery and quality of life require an individualized approach

EPMA Journal

Volumn 1, Issue 1, 2010, Pages 82-87

  Schrader, Wolfgang F ^a   Josifova, Tatjana ^b  

^a Maximilians Augenklinik   (Germany)

^b UNIVERSITY EYE CLINIC   (Switzerland)

Author keywords

Diabetic retinopathy; Drug assisted vitrectomy; Ocular hypertension; Postoperative inflammation; Prophylaxis; Quality of life; Small incision ocular microsurgery

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE; EYE DROPS; OCRIPLASMIN; RANIBIZUMAB; STEROID; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN INHIBITOR;

ASTIGMATISM; CATARACT; CONVALESCENCE; DIABETES MELLITUS; DIABETIC RETINOPATHY; EXTRACAPSULAR CATARACT EXTRACTION; EYE INJURY; EYE SYNECHIA; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; INTRAOCULAR HYPERTENSION; INTRAOPERATIVE AWARENESS; LENS CAPSULE RUPTURE; LENS IMPLANTATION; NUCLEOTIDE SEQUENCE; OPERATION DURATION; OUTCOME ASSESSMENT; PEROPERATIVE COMPLICATION; PERSONALIZED MEDICINE; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; QUALITY OF LIFE; RETINA DETACHMENT; RETINA NEOVASCULARIZATION; REVIEW; RISK REDUCTION; SURGICAL APPROACH; SURGICAL INJURY; TREATMENT PLANNING; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 79953036390     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1007/s13167-010-0008-3     Document Type: Review

References (41)

1. Deutsche Diabetes Union (ed.) Deutscher Gesundheitsbericht Diabetes 2007. In, Mainz; 2006.
2. Hesse L, Heller G, Kraushaar N, et al. Klinische Bedeutung einer Stadieneinteilung der proliferativen diabetischen Vitreoretinopathie. [The predictive value of a classification for proliferative diabetic vitreoretinopathy]. Klin Monatsbl Augenheilkd. 2002;219:46-9.
3. Scharwey K, Pavlovic S, Jacobi KW. Combined clear corneal phacoemulsification, vitreoretinal surgery, and intraocular lens implantation. J Cataract Refract Surg. 1999;25:693-8.
4. Livingstone BI, Bourke RD. Retrospective study of macular holes treated with pars plana vitrectomy. Aust N Z J Ophthalmol. 1999;27:331-41.
5. Scharwey K, Pavlovic S, Jacobi KW. Fruhe Hinterkapselfibrose nach kombinierter Katarakt- und vitreoretinaler Chirurgie mit intraokularer Luft/SF6-Gastamponade. Klin Monatsbl Augenheilkd. 1998;212:149-53.
6. Gnad HD. Die Vitrektomie via pars plana. Eine histologische Studie und Analyse klinischer Ergebnisse.[Vitrectomy via pars plana. A histological study and an analysis of clinical results (author's transl)]. Wien Klin Wochenschr Suppl. 1980;108:1-22.
7. Thompson JT, De Bustros S, Michels RG, et al. Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the macula. Arch Ophthalmol. 1987;105:497-502.
8. Eifrig DE, Hermsen V, Mcmanus P, et al. Rubeosis capsulare. J Cataract Refract Surg. 1990;16:633-6.
9. Oldendoerp J, Spitznas M. Der Einfluss von Rubeosis iridis und aktiven Neovaskularisationen am Fundus auf die Ergebnisse der Glaskorperchirurgie bei der proliferativen diabetischen Retinopathie. [Effect of rubeosis iridis and active neovascularization of the fundus on vitreous surgery in diabetic retinopathy]. Klin Monbl Augenheilkd. 1988;192:650-9.
10. Biermeyer H, Kroll P. Vorschlag zur Linsenimplantation nach vitreoretinaler Silikonoelchirurgie. [Recommendation for lens implantation following vitreoretinal silicone oil surgery]. Klin Monbl Augenheilkd. 1990;197:6-8.
11. Hui Y, Wang L, Huang W, et al. Simultaneous intraocular lens implantation during vitreous surgery for treatment of proliferative diabetic retinopathy. Zhonghua Yan Ke Za Zhi. 2002;38:598-602.
12. Pardo-Munoz A, Muriel-Herrero A, Abraira V, et al. Phacoemulsification in previously vitrectomized patients: an analysis of the surgical results in 100 eyes as well as the factors contributing to the cataract formation. Eur J Ophthalmol. 2006;16:52-9.
13. Jun Z, Pavlovic S, Jacobi KW. Results of combined vitreoretinal surgery and phacoemulsification with intraocular lens implantation. Clin Exp Ophthalmol. 2001;29:307-11.
14. Schrader WF, Unger S. Kataraktoperation kombiniert mit Parsplana Vitrektomie bei diabetischer Retinopathie im Vergleich zu anderen Indikationen. Klin Monatsbl Augenheilkd. 2002;220:S31.
15. Unger S. Beeinflussung der postoperativen Entzündungsreaktion nach kombinierter PPV mit Kataraktoperation und Hinterkammerlinsenimplantation bei Diabetikern und Nichtdiabetikern In: Dept. of Ophthalmology. University of Würzburg, Würzburg 2005.
16. Leyland MD, Schulenburg WE. Combined phacoemulsification- vitrectomy surgery: technique, indications and outcomes. Eye. 1999;13:348-52.
17. Tseng HY, Wu WC, Hsu SY. Comparison of vitrectomy alone and combined vitrectomy, phacoemulsification and intraocular lens implantation for proliferative diabetic retinopathy. Kaohsiung J Med Sci. 2007;23:339-43.
18. Foster RE, Lowder CY, Meisler DM, et al. Combined extracapsular cataract extraction, posterior chamber intraocular lens implantation, and pars plana vitrectomy. Ophthalmic-Surg. 1993;24:446-52.
19. Suzuki Y, Sakuraba T, Mizutani H, et al. Postoperative complications after simultaneous vitrectomy and cataract surgery. Ophthalmic Surg Lasers. 2001;32:391-6.
20. Rivas-Aguino P, Garcia-Amaris RA, Berrocal MH, et al. Vitrectomia pars plana, facoemulsificacion e implante de lente intraocular para el manejo de catarata y retinopatia diabetica proliferativa: comparacion de tecnica quirurgica combinada versus en dos tiempos. [Pars plana vitrectomy, phacoemulsification and intraocular lens implantation for the management of cataract and proliferative diabetic retinopathy: comparison of a combined versus two-step surgical approach]. Arch Soc Esp Oftalmol. 2009;84:31-8.
21. Schrader WF, Schunder S. Postoperative recovery following 23G vitrectomy is not delayed by a simultaneous clear cornea phacoemulsification. In: 107. DOG-Kongress. Leipzig; 2009.
22. Diolaiuti S, Senn P, Schmid MK, et al. Combined pars plana vitrectomy and phacoemulsification with intraocular lens implantation in severe proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging. 2006;37:468-74.
23. Nawrocki J, Michalewska Z, Michalewski J, et al. Cool phaco in combined phacoemulsification and vitrectomy surgery. Klin Oczna. 2006;108:16-9.
24. Lott MN, Manning MH, Singh J, et al. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications. Retina. 2008;28:1193-200.
25. Schrader WF, Schunder S, Unger S. Hat die 23G-Vitrektomie kombiniert mit Phakoemulsifikation der Linse in Clear Cornea Technik Vorteile gegenüber der klassischen Vitrektomie. In: Tetz MR, Auffahrt GU, Pham DT, editors. 22. Kongress der Deutschsprachigen Gesellschaft für Intraokularlinsen-Implantation, Interventionelle und Refraktive Chirurgie. Köln: Biermann Verlag; 2009. p. 267-75.
26. Valmaggia C. Pars plana vitrectomy with 25-gauge instruments in the treatment of idiopathic epiretinal membranes. Klin Monatsbl Augenheilkd. 2007;224:292-6.
27. Chang CJ, Chang YH, Chiang SY, et al. Comparison of clear corneal phacoemulsification combined with 25-gauge transconjunctival sutureless vitrectomy and standard 20-gauge vitrectomy for patients with cataract and vitreoretinal diseases. J Cataract Refract Surg. 2005;31:1198-207.
28. Birinci H. Surgical results of triamcinolone assisted pars plana vitrectomy combined with phacoemulsification in diabetic patients. Open Ophthalmol J. 2008;2:5-8.
29. Vasconcelos-Santos DV, Nehemy PG, Schachat AP, et al. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors. Retina. 2008;28:573-80.
30. Jaissle GB, Bartz-Schmidt KU, Szurman P. Optikusatrophie nach epiretinalen Triamcinolon-Ablagerungen in einem Auge mit entfernter Membrana limitans interna. [Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling]. Ophthalmologe. 2008;105:575-77.
31. Szurman P, Sierra A, Kaczmarek R, et al. Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo. Exp Eye Res. 2007;85:44-53.
32. Lopez-Lopez F, Rodriguez-Blanco M, Gomez-Ulla F, et al. Enzymatic vitreolysis. Curr Diabetes Rev. 2009;5:57-62.
33. Gandorfer A. Objective of pharmacologic vitreolysis. Dev Ophthalmol. 2009;44:1-6.
34. Stefansson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol. 2009;247:147-63.
35. Matsuyama K, Ogata N, Jo N, et al. Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab. Jpn J Ophthalmol. 2009;53:243-8.
36. Modarres M, Nazari H, Falavarjani KG, et al. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol. 2009;19:848-52.
37. Ahmadieh H, Shoeibi N, Entezari M, et al. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ophthalmology. 2009;116:1943-8.
38. Kellner L, Wimpissinger B, Stolba U, et al. 25-gauge vs 20-gauge system for pars plana vitrectomy: a prospective randomized clinical trial. Br J Ophthalmol. 2007;91:945-8.
39. Lahey JM, Francis RR, Kearney JJ, et al. Combining phacoemulsification and vitrectomy in patients with proliferative diabetic retinopathy. Curr Opin Ophthalmol. 2004;15:192-6.
40. Lahey JM, Francis RR, Kearney JJ. Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases. Ophthalmology. 2003;110:1335-9.
41. Ando A, Nishimura T, Uyama M. Surgical outcome on combined procedures of lens extraction, intraocular lens implantation, and vitrectomy during removal of the epiretinal membrane. Ophthalmic Surg Lasers. 1998;29:974-9.